Bensalem, A., Mulleman, D., Paintaud, G., Azzopardi, N., Gouilleux-Gruart, V., Cornec, D., Specks, U., Ternant, D., 2020. Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited. Clin Pharmacokinet 59, 519–530. https://doi.org/10.1007/s40262-019-00826-5
Bensalem, A., Ternant, D., 2020. Pharmacokinetic Variability of Therapeutic Antibodies in Humans: A Comprehensive Review of Population Pharmacokinetic Modeling Publications. Clin Pharmacokinet. https://doi.org/10.1007/s40262-020-00874-2
Bodin, A., Bisson, A., Gaborit, C., Herbert, J., Clementy, N., Babuty, D., Lip, G.Y.H., Fauchier, L., 2020. Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions. Stroke 51, 1674–1681. https://doi.org/10.1161/STROKEAHA.120.029048
Dănilă, M.-D., Piollet, M., Aburel, O.-M., Angoulvant, D., Lefort, C., Chadet, S., Roger, S., Muntean, M.-D., Ivanes, F., 2020. Modulation of P2Y11-related purinergic signaling in inflammation and cardio-metabolic diseases. Eur. J. Pharmacol. 876, 173060. https://doi.org/10.1016/j.ejphar.2020.173060
Chadet S, Ternant D, Roubille F, Bejan-Angoulvant T, Prunier F, Mewton N, Paintaud G, Ovize M, Dupuy AM, Angoulvant D, Ivanes F.,  Kinetic modelling of myocardial necrosis biomarkers offers an easier, reliable and more acceptable assessment of infarct size. Sci Rep. 2020 Aug 12;10(1):13597. doi: 10.1038/s41598-020-70501-4.
https://pubmed.ncbi.nlm.nih.gov/32788683/

 
Poisson L, Lopez-Charcas O, Chadet S, Bon E, Lemoine R, Brisson L, Ouaissi M, Baron C, Besson P, Roger S, Moussata D. Rock inhibition promotes NaV1.5 sodium channel-dependent SW620 colon cancer cell invasiveness.  Sci Rep. 2020 Aug 7;10(1):13350. doi: 10.1038/s41598-020-70378-3
https://pubmed.ncbi.nlm.nih.gov/32770034/
 
Brisson L., Chadet S., Lopez-Charcas O., Jelassi B., Ternant D., Chamouton J., Lerondel S., Le Pape A., Couillin I., Gombault A., Trovero F., Chevalier S., Besson P., Jiang L.-H. , Roger S. P2X7 receptor promotes mouse mammary cancer cell invasiveness and tumour progression, and is a target for anticancer treatment. Cancers. 2020, 12, 2342; doi:10.3390/cancers12092342
https://pubmed.ncbi.nlm.nih.gov/32825056/
 
Granel J, Lemoine R, Morello E, Gallais Y, Mariot J, Drapeau M, Musnier A, Poupon A, Pugnière M, Seren S, Nouar D, Gouilleux-Gruart V, Watier H, Korkmaz B, Hoarau C. 4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis. Front.Immunol. 2020 Sept 25.
https://doi.org/10.3389/fimmu.2020.573040